Chemeq names new CEO
Tuesday, 26 July, 2005
Antimicrobial specialist Chemeq (ASX:CMQ) has named David Williams its new CEO and director, commencing August 1. Williams was formerly CEO of Epic Energy, a gas transmission company.
Chemeq's founder scientist, Graham Melrose, will remain executive chairman until a new chairman is appointed.
The company also announced that it has banked AUD$20 million after the allotment of 20,000 convertible bonds with a face value of $1000 each to Mizuho International, Stark Trading and Shepherd Investments. An aggregate additional subscription fee of $350,000 has been paid to the three companies.
TGA approves donanemab for treatment of early Alzheimer's
The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in...
Ultra-processed foods linked to poor health, premature death
Evidence suggests a dose-response relationship between ultra-processed food consumption and...
Shorter radiotherapy course proves safe for prostate cancer
A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...
